Then, we assessed the sensitivity of these SCLC cell lines to a bromodomain inhibitor, JQ1, since the effects of JQ1 on the reduction of MYC and MYCN expression associated with growth inhibition have been reported in several other types of cancers [13, 14, 21-25]. The gene discussed is MYCN; the disease is cancer.